About MPCC
Advancing Pharma Excellence
Mesned Pharma Consult Co. (MPCC) is a Saudi pharma consulting and the first SFDA-licensed firm, helping local and global life sciences companies navigate complex regulatory landscapes across Saudi Arabia, the GCC, and the MENA region.
At MPCC, our expertise spans regulatory affairs, pharmacovigilance, quality, clinical, and end-to-end pharma solutions, driving effective market entry and expansion across the region.
Years of combined experience
Founded in Saudi Arabia
1st Pharma Consulting
Licensed by SFDA
Globally
Recognized
OUR STORY
Pioneering Pharma Excellence in MENA
Mesned Pharma Consult Co. (MPCC) was founded in 2005, becoming the first SFDA-licensed pharmaceutical consulting firm in Saudi Arabia.
From the outset, MPCC set out to advance regulatory excellence and bridge the gap between the evolving Saudi regulatory landscape and life sciences companies, serving as an expert local partner to navigate SFDA requirements.
Headquartered in Saudi Arabia, with offices in Jordan and Egypt, MPCC has grown into a regional regulatory hub, delivering end-to-end support in regulatory affairs, pharmacovigilance, clinical, and quality systems across Saudi Arabia, the GCC, and MENA.
Two decades on, MPCC stands as a strategic partner for local and global pharmaceutical, biotech, and MedTech companies, guiding successful market entry, full regulatory compliance, and sustainable growth.
Regulatory Excellence. Simplified.
Your Compliance Success Partner.
Mission
To deliver comprehensive, turnkey pharma solutions across the MENA region for pharmaceutical, biotech, and MedTech companies, combining deep industry expertise with strategic, compliant execution.
Vision
To drive transformative impact in the healthcare industry and be the trusted pharma partner of choice for local and global life sciences companies operating in Saudi Arabia and MENA, enabling sustainable growth.
CSR
Supporting healthcare communities through ethical practices, nurturing skills development, and driving impactful education initiatives.
LEADERSHIP
Meet Our Leadership
Projects Director
Mr. Bilal Zaza
+25 Years of Experience
Founder & CEO
Dr. Abdullah Fahed Al-Mesned
30+ Years of Experience
General Director
Dr. Lina Musallam
21+ Years of Experience
SPECIALIZED TEAMS
Our Teams
At MPCC, our teams cover all key areas of the pharmaceutical industry, bringing deep knowledge of Saudi and regional regulations. MPCC consultants include former SFDA regulators and licensed pharmacists, driven by a culture of collaboration, excellence, and continuous learning.
Functioning as a full-service pharma advisory partner, the MPCC team delivers efficient execution, working seamlessly with clients to navigate regulations, accelerate approvals, and achieve sustainable market success.
Regulatory Affairs Team
Specializing in SFDA and MENA regulatory pathways, managing efficient pre-marketing and post-marketing submissions and approvals for all pharmaceutical products.
Pharmacovigilance Team
Managing end-to-end pharmacovigilance activities, including acting as your local QPPV in Saudi Arabia, ensuring full compliance with SFDA requirements.
Quality Assurance Team
Covering all aspects of quality assurance, including QMS, GMP readiness, audits, and ISO guidance, securing SFDA and global compliance.
Governmental Affairs Team
Providing strategic regulatory guidance and support for licensing, approvals, establishment registration, authority engagement, and market entry in Saudi Arabia.
Inspection Team
Expert inspectors providing comprehensive support, including mock audits, gap analysis, CABA, and on-site guidance, ensuring SFDA and regulatory inspection readiness.
Business Development Team
Building strategic partnerships and delivering actionable strategies to support pharma, biotech, and MedTech clients’ success in Saudi Arabia.
Our Corporate Family
Comprehensive Solutions, Unified Vision
MPCC is the regulatory consulting arm of a diverse corporate family. As a subsidiary of Bana Medical Group, our reach extends across five specialized sister companies, enabling us to offer our partners the stability of a large organization combined with the agility of a focused consultancy.
